Sarcoma

Table of Contents: 2013

  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 947413
  • - Research Article

Costs Associated with Intravenous Cancer Therapy Administration in Patients with Metastatic Soft Tissue Sarcoma in a US Population

Mei Sheng Duh | Michelle D. Hackshaw | ... | Bruce Wong
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 982784
  • - Research Article

Can Experienced Observers Differentiate between Lipoma and Well-Differentiated Liposarcoma Using Only MRI?

Patrick W. O'Donnell | Anthony M. Griffin | ... | Peter C. Ferguson
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 868973
  • - Clinical Study

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Juan Martin-Liberal | Salma Alam | ... | Charlotte Benson
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 404962
  • - Research Article

Reduced Latency in the Metastatic Niche Contributes to the More Aggressive Phenotype of LM8 Compared to Dunn Osteosarcoma Cells

Matthias J. E. Arlt | Ingo J. Banke | ... | Bruno Fuchs
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 725305
  • - Research Article

Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden

Julian F. Guest | Monica Panca | ... | Mark Linch
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 365723
  • - Research Article

Rapid Screening of Novel Agents for Combination Therapy in Sarcomas

Christopher L. Cubitt | Jiliana Menth | ... | Damon R. Reed
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 321201
  • - Clinical Study

The Vascularized Fibular Graft in the Pediatric Upper Extremity: A Durable, Biological Solution to Large Oncologic Defects

Nicki Zelenski | Brian E. Brigman | ... | William C. Eward
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 360214
  • - Clinical Study

Safety and Efficacy of Stereotactic Body Radiation Therapy in the Treatment of Pulmonary Metastases from High Grade Sarcoma

Niraj Mehta | Michael Selch | ... | Percy Lee
  • Sarcoma -
  • Special Issue
  • - Volume 2013
  • - Article ID 641687
  • - Editorial

Osteosarcoma: Lessons Learned and Future Avenues

Ajay Puri | Norman Jaffe | Hans Gelderblom
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 798403
  • - Research Article

Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases

Jennifer Hung | Susan M. Hiniker | ... | Joseph M. Herman
  • Sarcoma -
  • Special Issue
  • - Volume 2013
  • - Article ID 648393
  • - Editorial

Biological Reconstruction for Sarcoma

Andreas Leithner | Per-Ulf Tunn | Pietro Ruggieri
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 439213
  • - Clinical Study

Outcome of Rhabdomyosarcoma in First Year of Life: Children’s Cancer Hospital 57357 Egypt

Enas El Nadi | Emad A. H. Moussa | ... | Rania M. Labib
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 316123
  • - Clinical Study

Osteosarcoma: A Comparison of Jaw versus Nonjaw Localizations and Review of the Literature

H. van den Berg | W. H. Schreuder | J. de Lange
  • Sarcoma -
  • Special Issue
  • - Volume 2013
  • - Article ID 826432
  • - Editorial

Recent Developments in the Surgical Treatment of Bone Tumors and Their Impact on Quality of Life

Andreas F. Mavrogenis | Ulrich Lenze | ... | Pietro Ruggieri
  • Sarcoma -
  • Special Issue
  • Volume 2013
  • - Article ID 548628
  • - Clinical Study

Metastatic Pattern, Local Relapse, and Survival of Patients with Myxoid Liposarcoma: A Retrospective Study of 45 Patients

Hanna M. Fuglø | Katja Maretty-Nielsen | ... | Michael M. Petersen
Sarcoma
 Journal metrics
Acceptance rate47%
Submission to final decision67 days
Acceptance to publication55 days
CiteScore2.500
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.